Dabrafenib plus trametinib versus anti-PD-1 monotherapy as adjuvant therapy in BRAF V600-mutant stage III melanoma after definitive surgery: a multicenter, retrospective cohort study
- Resource Type
- article
- Source
- EClinicalMedicine, Vol 71, Iss , Pp 102564- (2024)
- Subject
Medicine (General) R5-920 - Language
- English
- ISSN
- 2589-5370